Total Payments
$191,173
2024 Payments
$12,586
Companies
39
Transactions
607
Medicare Patients
6,289
Medicare Billing
$834,534
Payment Breakdown by Category
Other$157,740 (82.5%)
Travel$17,751 (9.3%)
Food & Beverage$13,096 (6.9%)
Consulting$2,513 (1.3%)
Education$74.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $157,740 | 76 | 82.5% |
| Travel and Lodging | $17,751 | 30 | 9.3% |
| Food and Beverage | $13,096 | 493 | 6.9% |
| Consulting Fee | $2,513 | 3 | 1.3% |
| Education | $74.50 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $171,602 | 297 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $12,994 | 11 | $0 (2022) |
| Janssen Biotech, Inc. | $1,922 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $815.27 | 58 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $544.81 | 35 | $0 (2023) |
| Allergan Inc. | $438.18 | 48 | $0 (2019) |
| Merck Sharp & Dohme LLC | $302.97 | 22 | $0 (2024) |
| PFIZER INC. | $232.82 | 12 | $0 (2024) |
| Covidien LP | $208.51 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $202.14 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,586 | 46 | ABBVIE INC. ($12,120) |
| 2023 | $27,450 | 66 | ABBVIE INC. ($25,389) |
| 2022 | $22,991 | 67 | ABBVIE INC. ($18,605) |
| 2021 | $16,729 | 70 | Janssen Scientific Affairs, LLC ($9,287) |
| 2020 | $4,279 | 23 | AbbVie Inc. ($4,083) |
| 2019 | $45,939 | 126 | AbbVie, Inc. ($44,746) |
| 2018 | $36,690 | 114 | AbbVie, Inc. ($35,889) |
| 2017 | $24,508 | 95 | AbbVie, Inc. ($23,859) |
All Payment Transactions
607 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $97.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $35.36 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: INFLIXIMAB | ||||||
| 08/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $970.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $97.52 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Gastroenterology | ||||||
| 06/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology | ||||||
| 06/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $123.07 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,709 | 1,888 | $1.2M | $189,800 |
| 2022 | 22 | 1,706 | 8,827 | $1.5M | $305,296 |
| 2021 | 26 | 1,527 | 1,721 | $1.1M | $184,535 |
| 2020 | 23 | 1,347 | 1,518 | $899,377 | $154,903 |
Total Patients
6,289
Total Services
13,954
Medicare Billing
$834,534
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 260 | 261 | $360,180 | $53,496 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 362 | $127,062 | $32,193 | 25.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 128 | 128 | $130,688 | $22,847 | 17.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 204 | 209 | $203,357 | $12,085 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $41,454 | $10,767 | 26.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 94 | 95 | $106,970 | $8,045 | 7.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 129 | $24,983 | $7,949 | 31.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 73 | 75 | $27,525 | $7,667 | 27.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 39 | 39 | $39,819 | $6,986 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 99 | $24,453 | $6,557 | 26.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 59 | 64 | $64,192 | $6,518 | 10.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $37,777 | $4,578 | 12.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 24 | 27 | $9,531 | $2,519 | 26.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 26 | $24,241 | $2,219 | 9.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 37 | 46 | $7,038 | $1,673 | 23.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 21 | $5,187 | $1,485 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,468 | $871.19 | 25.1% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 41 | 41 | $4,428 | $871.14 | 19.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 98 | 98 | $2,156 | $460.87 | 21.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 12 | 25 | $125.00 | $12.27 | 9.8% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 11 | 6,900 | $285,246 | $115,401 | 40.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 221 | 221 | $304,980 | $44,341 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 255 | 361 | $126,711 | $32,186 | 25.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 103 | 103 | $105,163 | $18,856 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 116 | 116 | $51,156 | $12,369 | 24.2% |
About Dr. Brian Hyett, M.D
Dr. Brian Hyett, M.D is a Internal Medicine healthcare provider based in Portsmouth, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972722015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Hyett, M.D has received a total of $191,173 in payments from pharmaceutical and medical device companies, with $12,586 received in 2024. These payments were reported across 607 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($157,740).
As a Medicare-enrolled provider, Hyett has provided services to 6,289 Medicare beneficiaries, totaling 13,954 services with total Medicare billing of $834,534. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Portsmouth, NH
- Active Since 04/25/2007
- Last Updated 09/30/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972722015
Products in Payments
- Humira (Biological) $83,032
- SKYRIZI (Biological) $38,415
- STELARA (Biological) $14,913
- HUMIRA (Biological) $7,453
- RINVOQ (Biological) $6,122
- XIFAXAN (Drug) $586.64
- LINZESS (Drug) $464.53
- CREON (Drug) $266.89
- XELJANZ (Drug) $232.82
- ENTYVIO (Biological) $214.36
- VIBERZI (Drug) $213.56
- GATTEX (Drug) $165.19
- Entyvio (Biological) $156.27
- OCALIVA (Drug) $139.60
- DIFICID (Drug) $137.30
- DUPIXENT (Biological) $136.73
- PillCam (Device) $134.34
- Mavyret (Drug) $111.35
- CLENPIQ (Drug) $110.28
- Epclusa (Drug) $110.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portsmouth
Dr. Magued Rizkalla Hanna, Md, MD
Internal Medicine — Payments: $65,528
Internal Medicine $65,528
Emily Perdoncin, Md, MD
Internal Medicine — Payments: $22,958
Internal Medicine $22,958
Dr. Elie Saab, Md, MD
Internal Medicine — Payments: $16,442
Internal Medicine $16,442
Dr. Ronald Arrick, M.d, M.D
Internal Medicine — Payments: $8,708
Internal Medicine $8,708
Dr. Kevin Kammler, D.o, D.O
Internal Medicine — Payments: $8,317
Internal Medicine $8,317
Dr. Sarthak Khare, Md, MD
Internal Medicine — Payments: $4,489
Internal Medicine $4,489